Antivirals Market

Antivirals Market - Global Market Share, Trends, Analysis and Forecast, 2023-2032
Frequently asked questions about this report

Antiviral drugs are chemicals or drugs that directly attack the disease-causing virus instead of relying on immunity-based approaches.

HIV and Covid-19 pandemic are recent drivers of this market. However, development in existing knowledge and technology in antiviral treatment has been influential in the long run.

Antivirals are a group of medications that can directly attack the virus instead of traditional immunogenic and anti-inflammatory treatments.

The global antivirals market is estimated to expand at a CAGR of 3.6% between 2023 to 2032.

The global antivirals market size was estimated to be US$ 47.7 billion in 2021.

The current dominance of antivirals is observed in North American regions, especially in the United States. With the largest share of pharmaceutical companies present within its borders, the United States is leading the development of the antivirals market.

AbbVie, Inc., Aurobindo Pharma Limited., Bristol-Myers Squibb, Cipla, Inc., GlaxoSmithKline PLC., Gilead Sciences, Johnson & Johnson, Sun Pharmaceutical Industries Ltd., etc. have been involved in development and progression of antiviral medication across the globe.